Copyright
©The Author(s) 2017.
World J Diabetes. Mar 15, 2017; 8(3): 112-119
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.112
Published online Mar 15, 2017. doi: 10.4239/wjd.v8.i3.112
Table 4 Genotype distributions and allele frequency for angiotensin converting enzyme and angiotensinogen gene polymorphisms
| Gene | n = 252 | Genotype/allele | Percentage (%) |
| ACE (I/D) | Genotypic frequency | II | 31 |
| ID | 53 | ||
| DD | 16 | ||
| Allele frequency | I | 57 | |
| D | 43 | ||
| AGT (M235T) | Genotypic frequency | MM | 25 |
| MT | 53 | ||
| TT | 22 | ||
| Allele frequency | M | 51 | |
| T | 49 |
- Citation: Aggarwal N, Kare PK, Varshney P, Kalra OP, Madhu SV, Banerjee BD, Yadav A, Raizada A, Tripathi AK. Role of angiotensin converting enzyme and angiotensinogen gene polymorphisms in angiotensin converting enzyme inhibitor-mediated antiproteinuric action in type 2 diabetic nephropathy patients. World J Diabetes 2017; 8(3): 112-119
- URL: https://www.wjgnet.com/1948-9358/full/v8/i3/112.htm
- DOI: https://dx.doi.org/10.4239/wjd.v8.i3.112